Target intelligence / Profile preview

Sodium bicarbonate cotransporter 3 (SLC4A7)

Target
SLC4A7
Molecular classification
Transporter, Solute carrier (SLC) family, Ion transporter
01

Overview

Sodium bicarbonate cotransporter 3 (SLC4A7, also known as NBCn1) is a member of the solute carrier family 4, functioning as an electroneutral sodium and bicarbonate cotransporter found in the plasma membrane of many cell types including those in the nervous, cardiovascular, and gastrointestinal systems[2][4][5][6]. By coupling the movement of Na⁺ and HCO₃⁻ ions, SLC4A7 plays a crucial role in regulating intracellular pH, acid–base homeostasis, and transepithelial movement of electrolytes. The transporter exists in numerous splice variants and participates in net acid extrusion, cellular volume regulation, and modulation of cell survival. Dysfunction has been linked to cardiovascular pathologies, certain cancers, and potentially neurological diseases[2][5][6]. While targeted inhibitors are under research for cancer therapy, no approved drugs currently act directly on SLC4A7, making it a promising but as-yet underexploited therapeutic target[2].

Other names
NBCn1Na⁺/HCO₃⁻ cotransporterSolute carrier family 4 member 7
02

Mechanism of action

Inhibitors block sodium and bicarbonate ion cotransport for modulation of pH and cell viability, particularly in cancer therapeutics research[2]

03

Biological functions

Acid–base homeostasisIntracellular pH regulationTransepithelial electrolyte transportCell volume regulationCell viability modulation
04

Disease associations

Cardiovascular diseaseCancerNeurodegenerationOther (including potential kidney and central nervous system pathologies)
05

Safety considerations

Disruption can cause acid–base imbalanceimpaired cell viabilitycomplications in vital tissues (cardiovascular, nervous system)[2]
06

Interacting drugs

Few small molecule inhibitors identified in research; no widely-used clinical drugs directly targeting SLC4A7 as of current knowledge[2]
07

Biomarkers

Potential biomarker in some cancers (e.g., breast cancer) and cardiovascular disordersresearch application as indicator of pH regulatory activity[2]

Beyond the preview

Go deeper on Sodium bicarbonate cotransporter 3 (SLC4A7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium bicarbonate cotransporter 3 (SLC4A7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call